Moderna (MRNA) Options Chain & Prices $48.12 +2.40 (+5.25%) Closing price 04:00 PM EasternExtended Trading$48.08 -0.04 (-0.08%) As of 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MRNA Put and Call Options List 12/15/2028 1/21/2028 12/17/2027 6/17/2027 3/19/2027 1/15/2027 12/18/2026 10/16/2026 9/18/2026 8/21/2026 7/17/2026 6/26/2026 6/18/2026 6/12/2026 6/5/2026 5/29/2026 5/22/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades5/22/2026$39.00$0.029Put11 - 77(+2)87.74% (-5.52%)-0.02143915/22/2026$39.00$6.752Call2712354(+42)87.74% (-5.53%)0.978633275/22/2026$39.50$6.260Call48 - - 2(+2)84.90% (-6.34%)0.972978205/22/2026$40.00$0.046Put7 - 551(+13)82.20% (-7.04%)-0.0345425/22/2026$40.00$5.770Call21121(+2)82.20% (-7.06%)0.96554625/22/2026$40.50$0.060Put8717(+1)79.72% (-7.64%)-0.04444545/22/2026$40.50$5.284Call48 - - 3(+3)79.72% (-7.65%)0.955651205/22/2026$41.00$4.804Call1 - - 7(-19)77.52% (-8.08%)0.9423815/22/2026$41.50$0.107Put71 - 1(+0)75.66% (-8.28%)-0.07559835/22/2026$42.00$0.147Put206636053(+6)74.23% (-8.22%)-0.09941220 Get the Latest News and Ratings for MRNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moderna and its competitors with MarketBeat's FREE daily newsletter. 5/22/2026$42.50$0.202Put646117(+1)73.27% (-7.85%)-0.130554355/22/2026$42.50$3.427Call1 - - 65(+0)73.27% (-7.86%)0.86973515/22/2026$43.00$0.280Put3624273(+1)73.93% (-6.07%)-0.169996185/22/2026$43.00$3.006Call1 - - 3(+0)72.84% (-7.17%)0.83041415/22/2026$43.50$0.387Put398385820(+2)74.65% (-4.45%)-0.217802615/22/2026$44.00$0.526Put31625934321(+19)73.41% (-5.00%)-0.272822815/22/2026$44.00$2.251Call91413(+0)73.41% (-5.00%)0.7279735/22/2026$44.50$0.700Put134863342(+25)74.19% (-3.75%)-0.3329341005/22/2026$44.50$1.925Call1 - - 8(+0)74.19% (-3.75%)0.66811315/22/2026$45.00$0.908Put530265113762(+259)74.22% (-3.47%)-0.3957391115/22/2026$45.00$1.634Call51135(+0)75.11% (-2.58%)0.60559355/22/2026$45.50$1.151Put1436764116(+31)76.05% (-1.57%)-0.459098635/22/2026$46.00$1.425Put814724379(+43)76.99% (-0.27%)-0.521331615/22/2026$46.00$1.150Call25512213174(+0)75.86% (-1.88%)0.480631415/22/2026$46.50$1.730Put50153394(+8)77.90% (-0.09%)-0.581022265/22/2026$46.50$0.953Call209351715(+0)77.90% (-0.09%)0.421273345/22/2026$47.00$2.063Put561028227(+13)78.80% (+0.44%)-0.637065235/22/2026$47.00$0.785Call167579(-3)78.80% (+0.44%)0.36553105/22/2026$47.50$2.422Put15310122359(+21)79.70% (+0.89%)-0.688644275/22/2026$47.50$0.643Call2441826(+13)79.70% (+0.89%)0.31420575/22/2026$48.00$2.803Put34911312(+102)80.62% (+1.29%)-0.735234225/22/2026$48.00$0.524Call1206043447(+38)80.62% (+1.29%)0.267817385/22/2026$48.50$3.206Put17211193(+2)81.58% (+1.68%)-0.77663195/22/2026$48.50$0.425Call50261489(+42)81.58% (+1.68%)0.226604215/22/2026$49.00$3.626Put2122351(+67)82.58% (+2.08%)-0.81278995/22/2026$49.00$0.344Call22626135316(+135)82.58% (+2.08%)0.190565455/22/2026$49.50$4.061Put2 - - 18(+0)83.64% (+2.50%)-0.84388815/22/2026$49.50$0.278Call77707846(+73)83.64% (+2.50%)0.15953395/22/2026$50.00$4.509Put1321062481(+6)84.79% (+2.98%)-0.870266215/22/2026$50.00$0.225Call39611120911028(+610)83.10% (+1.28%)0.133185104I’m sounding the alarm (Ad)Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.Watch Stansberry's full investigation and see which companies to buy and sell5/22/2026$51.00$5.435Put7 - - 138(+0)87.41% (+4.14%)-0.91061445/22/2026$51.00$0.149Call595144401493(+60)87.41% (+4.14%)0.092794455/22/2026$52.00$6.390Put5 - - 110(-4)90.57% (+5.70%)-0.93771835/22/2026$52.00$0.102Call3861241588208(+154)90.57% (+5.70%)0.065576905/22/2026$53.00$7.363Put2 - - 1059(+1)94.33% (+7.69%)-0.9554215/22/2026$53.00$0.073Call10511311090(+59)94.33% (+7.69%)0.047739245/22/2026$54.00$8.346Put31 - 321(+1)98.69% (+10.07%)-0.96686235/22/2026$54.00$0.055Call28969898(-18)98.69% (+10.07%)0.036139145/22/2026$55.00$0.044Call14538782992(+37)103.53% (+12.68%)0.028495395/22/2026$56.00$10.330Put15 - 15116(-19)108.70% (+15.37%)-0.97952215/22/2026$56.00$0.037Call1481416554(+95)108.74% (+15.39%)0.02327385/22/2026$57.00$11.325Put11 - 28(+0)114.05% (+17.91%)-0.983215/22/2026$57.00$0.031Call13 - 6443(-497)114.05% (+17.89%)0.01959910End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies CRISPR Therapeutics Options Data Robinhood Markets Options Data Novavax Options Data Ocugen Options Data Regeneron Pharmaceuticals Options Data Tesla Options Data Johnson & Johnson Options Data Merck & Co., Inc. Options Data Pfizer Options Data Takeda Pharmaceutical Options Data Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:MRNA) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredIran War Update: Trump’s Hand-Written Letter Reveals What Comes NextJim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...Paradigm Press | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredThe $700 billion buy signal most investors are completely ignoringAmazon, Google, Meta, and Microsoft have committed $700 billion to AI infrastructure this year - more capital ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
